Podcasts about squamous

Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025.Click here to read the full articleContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Do you know where immunotherapy fits in the treatment paradigm of squamous cell anal carcinoma? Credit available for this activity expires: 9/3/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002850?ecd=bdc_podcast_libsyn_mscpedu

This podcast episode from Beyond the Clinic features a discussion between host Adam Redpath and equine medicine specialists Emma Shipman and Sarah Voss about gastric disease in horses. They discuss the significant differences in squamous and glandular diseases in terms of their etiology and management. Squamous disease is well-studied and responds to acid suppression with drugs like omeprazole. Glandular disease, less understood in its etiology, requires varied treatment strategies often tailored to the client's abilities. The experts agree that management of these conditions requires a holistic approach; careful medication selection plus consideration of the horse's management routine, nutrition and workload. Our Guests: Emma Shipman BVetMed MSc DACVIM-LAIM DipECEIM CertVA FHEA MRCVS RCVS and EBVS Recognised Specialist in Equine Internal Medicine Emma graduated from the RVC in 1999 and completed a residency in equine medicine at the Marion duPont Scott equine Medical Centre, Virginia-Maryland Regional College of Veterinary Medicine obtaining a masters in veterinary biomedical sciences and Diplomate status of the American College of Veterinary Internal medicine. Since then she has worked in both private practice and academia, being associate professor in equine medicine at the university of Nottingham since 2021.Sarah Voss BVMedSci (Hons) BVM BVS MVM DipECEIM FHEA MRCVS RCVS and European Equine Internal Medicine Specialist Sarah graduated from Nottingham in 2012. She completed an internship at Oakham then spent time in equine ambulatory practice before undertaking an Equine Internal Medicine Residency at the University of Glasgow. Sarah is a European and RCVS Equine Internal Medicine specialist and has also completed a Masters by research investigating the gastric microbiota associated with gastric disease in racehorses. Sarah currently works at Oakham and is also a Clinical Assistant Professor at the University of Nottingham. Our Host: Adam Redpath BVMS DipECEIM MRCVS Veterinary SurgeonAdam is a EBVS and RCVS Specialist in Equine Internal Medicine having successfully becoming an ECEIM Diplomat in 2021. He has spent the majority of his early career in clinical academic practice, having several roles at the University of Nottingham. More recently Adam has ventured into private practice having worked at both Donnington Grove and Oakham Veterinary Hospital as an equine internal medicine clinician over the past 18 months. Adam currently splits his time between his clinical role at Oakham Veterinary Hospital and as Equine Development Lead within the L&D team at IVC Evidensia. Powered by IVC Evidensia At IVC Evidensia we're building the world's best veterinary group, with a single purpose; healthy animals and happy owners. Visit ivcevidensia.co.uk to find out more, or follow us on social media. Please note that the views expressed by hosts and guests in this podcast do not necessarily reflect those of IVC Evidensia. Links:Oakham Veterinary hospital pages: www.oakhamvethospital.co.uk/referral/equine-referrals/referral-information4European College of Equine Internal Medicine Consensus Statement—Equine Gastric Ulcer Syndrome in Adult Horses https://pmc.ncbi.nlm.nih.gov/articles/PMC4858038/

A year after starting a business that took off like wildfire, Wally noticed her health began to suffer. Her hair started falling out in clumps, she was sleeping a lot, had a sore neck, and just couldn't get up in the morning. She saw several doctors who all agreed it was a cyst. But In August of 2018, when she began to have problems swallowing and breathing, she had a biopsy. The results showed that it was squamous cell carcinoma of the head and neck.  Wally was never one to take anyone's word without proof and researching things herself. When given the very limited treatment options, that didn't sit well with her. She had an inner knowing that she created the dis-ease and knew she could fix it. Following her intuition, Wally told her doctors that she would cure herself. Today, Wally has been cancer free for over 6 years.   She is passionate about health and helping people become aware of the power of healing with mindset, along with healthy lifestyle changes. Most importantly, Wally prioritizes laughing her way through the life she once never expected to have.   Instagram - https://www.instagram.com/healthy_mum_downunder/  Email Wally at wayneandwal@gmail.com ____________________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube ________________________ Thank you to our friends from The Healing Oasis for sponsoring this episode of the podcast.  The Healing Oasis is a first of its kind in beautiful British Columbia, Canada where we encourage the body to heal from cancer using alternative therapies & cancer fighting meals at a wellness retreat center in nature. Our top naturopathic cancer doctor will prescribe a protocol tailored specifically for you. There's no place quite like it. Start your healing journey today! Learn More about The Healing Oasis by visiting these links: Website   Testimonials Video Overview

  A talk with the author!  This article surveys several malignancies that can occur in the oral cavity—from salivary gland tumors to sarcomas—to highlight their presentations, pathology, and management. Andreina Sucre, MSc, RDH   Read by Jackie Sanders  https://www.rdhmag.com/pathology/article/55271904/beyond-squamous-cell-carcinoma-a-spectrum-of-oral-cavity-malignancies

In this episode of Feel Better, Feel Great, Dr. Andrea McSwain explores the deeper layers of skin cancer, toxic burden, and the powerful connection between your internal health and skin. Learn how to identify the three main types of skin cancer—basal cell, squamous cell, and melanoma—while discovering how detox pathways, inflammation, oxidative stress, and conventional skincare products contribute to skin damage. Packed with holistic prevention strategies like clean beauty swaps, anti-inflammatory nutrition, natural sun protection, and daily detox support, this episode empowers you to protect your skin from the inside out. Tune in to decode your body's signals, reduce your toxic load, and embrace radiant, resilient skin. #skincancerawareness #HolisticSkincare #DetoxYourSkin #FunctionalMedicine #NaturalHealth #OxidativeStress #ToxicBurden #CleanBeauty #AntiInflammatoryLifestyle

interviewed by Mona Sadeghpour, MD, FAAD

In this episode of the EquiConnect Podcast, Dr. Mike Pownall and co-host Karen Foell dive into the crucial topic of Equine Gastric Ulcer Syndrome (EGUS) with veterinarians Dr. Rafael Gomez and Dr. Natalie Sanza. They explore the different types of ulcers, common causes, and cutting-edge treatment approaches. Listeners will gain valuable insights into diagnosing and managing this prevalent condition in horses, as well as key strategies for prevention. Plus, get an exclusive look at the upcoming Gastroscopy Open House Event—a must-attend opportunity for horse owners to see gastroscopy in action. Whether you're a competitive rider, trainer, or dedicated horse owner, this episode is packed with expert knowledge to help keep your horse healthy and happy.Timestamps: [00:00:00] – Introduction to the EquiConnect Podcast and episode overview [00:01:00] – Meet the experts: Dr. Rafael Gomez & Dr. Natalie Senza [00:02:00] – What is Equine Gastric Ulcer Syndrome (EGUS)?[00:03:00] – The two types of gastric ulcers: Squamous vs. Glandular[00:04:30] – Causes of equine ulcers: Feeding, stress, and more[00:08:00] – How feeding schedules affect ulcer development[00:09:30] – Stress and its impact on gastric health[00:11:00] – Shocking statistics: How common are gastric ulcers?[00:14:00] – Diagnosing ulcers: Why gastroscopy is the gold standard[00:17:00] – Recognizing symptoms: Poor performance, weight loss, and more[00:19:00] – The role of treatment: Omeprazole, GastroGard, and other medications[00:25:00] – Preventing ulcers: The power of management & nutrition[00:31:00] – Three pillars of ulcer prevention: Management, supplements, and medication[00:34:00] – Post-treatment care: How to prevent relapse[00:36:00] – Exciting event: Gastroscopy Open House on March 22nd[00:40:00] – Final thoughts & key takeawaysNotable Quotes:“More than half of the horse population suffers from ulcers—whether they're in the wild or in competition.” – Dr. Rafael Gomez “The only way to diagnose ulcers with certainty is through gastroscopy—there is no magic test from the outside.” – Dr. Natalie Sanza “If we don't change management after treatment, ulcers can return in as little as two days.” – Dr. Rafael Gomez “Management is the best medicine. The right feeding schedule, turnout, and stress reduction are key.” – Dr. Natalie SanzaResources & Mentioned Topics:

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Unfortunately, brain metastases are very common in patients with non-small cell lung cancer (NSCLC). That's why the phase 3 TROPION-Lung01 trial examined the efficacy and safety of datopotamab deruxtecan (Dato-DXd) for advanced non-squamous NSCLC with brain metastases. Joining Dr. Jacob Sands to share the results presented at the 2024 ESMO Congress is thoracic medical oncologist Dr. Aaron Lisberg.

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Unfortunately, brain metastases are very common in patients with non-small cell lung cancer (NSCLC). That's why the phase 3 TROPION-Lung01 trial examined the efficacy and safety of datopotamab deruxtecan (Dato-DXd) for advanced non-squamous NSCLC with brain metastases. Joining Dr. Jacob Sands to share the results presented at the 2024 ESMO Congress is thoracic medical oncologist Dr. Aaron Lisberg.

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce news that the company's Investigational New Animal Drug (INAD), featuring a dissolvable doxorubicin-containing microneedle array, has been granted Minor Use in Major Species Designation or MUMS by the U.S. Food and Drug Administration. This designation marks a significant step forward for Medicus Pharma's mission to revolutionize veterinary oncology. The FDA's MUMS designation is a pivotal milestone, akin to the Orphan Drug status for human medicines. It offers Medicus Pharma an extended 7-year period of exclusive marketing rights following approval or conditional approval, provided the company fulfills all regulatory requirements for maintaining the designation. This exclusivity positions the company to make a profound impact on treating external squamous cell carcinoma (SCC) in horses. The innovative doxorubicin-containing microneedle array is a patent-protected, dissolvable transdermal patch designed with cellulose-based microneedles. These microneedles are tip-loaded with doxorubicin, a potent chemotherapy agent. When applied, the microneedles penetrate the stratum corneum layer of the skin, creating temporary microchannels. This allows the microneedles to reach the tumor, dissolve, and release doxorubicin directly into the targeted area, effectively eradicating cancer cells while minimizing systemic side effects. Squamous cell carcinoma is a significant concern in horses, particularly in adult or aged animals with white or partially white coats. Breeds such as Appaloosa, Belgian, American Paint, and Pinto are especially susceptible. SCC typically develops in areas with minimal pigmentation and sparse hair, often around mucous membranes. Commonly affected areas include the eyes, lips, nose, anus, and external genitalia. With an overall incidence rate of 2-3%, this condition impacts a notable portion of the U.S. horse population, estimated to be between 6.6 and 7.25 million horses. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #CancerTreatment #HorseHealth #FDAApproval #InnovationInMedicine #SquamousCellCarcinoma #EquineCare #RazaBokhari #MUMSDesignation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

In episode 162 of The Johnny Rogers Show, I sit down with Bennet Reilly to dive into his unique perspectives and experiences. Bennet's word of choice for this episode was “Squamous,” a nod to his admiration for the works of H.P. Lovecraft. We discuss his appreciation for Lovecraft's life and literary contributions, as well as the enduring appeal of cosmic horror. The conversation spans a wide array of topics, including Bennet's work as a funeral director, Donald Trump's presidency, the origins of cancel culture with Donglegate, reflections on the Obama years, the rise of AI in the workforce, and the pressing need for a digital bill of rights to safeguard free speech. This episode is a thoughtful and engaging exploration of history, culture, and technology, with plenty of humor woven throughout. Don't miss it!

Description: In this virtual tumor board episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of a patient with metastatic squamous NSCLC. Listen to the episode to learn how the guests would approach this case. Guest: Dr. Pilar Garrido is an Associate Professor of Medical Oncology at Universidad de Alcalá in Madrid, Spain, and the Head of the Thoracic Tumours Section at the University Hospital Ramón y Cajal X: @Piuchagarrido Guest: Dr. Jared Weiss is a Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology at the University of North Carolina, Chapel Hill, N.C. @DrJaredWeiss

 Let's clear up the confusion and prevent unnecessary biopsies! Quick Summary of the Episode: In this episode, Brett Beckman, a board-certified veterinary dentist, dives deep into differentiating oral inflammation and stomatitis in cats, with a focus on histopathology and common misconceptions. Dr. Beckman also answers questions on oral masses, providing guidance on when to refer cases to a board-certified veterinary dentist.     Guest, Cast, and Crew Information: Host: Brett Beckman, DVM, FAVD, DAVDC, DAAPM (Board Certified Veterinary Dentist) Special Mention: Dr. Cindy Bell (Pathologist for Oral Histopathology)     Main Talking Points: The role of histopathology in diagnosing oral conditions in cats. The difference between feline stomatitis and gingivitis. When to biopsy a case of feline oral inflammation. The importance of referring to a board-certified veterinary dentist for oral masses.     Interesting Quotes From the Episode: "Not all oral inflammation is feline gingivostomatitis. The key is caudal oral mucosal inflammation." "The only reason I would biopsy is if there's a unilateral mass—99% of the time, it's likely squamous cell carcinoma." "Always refer to a board-certified dentist; they've undergone practical exams for perfect execution."     Timestamps for Major Segments: 00:00-01:00 – Introduction and sponsor mention (Veterinary Dental Practitioner Program). 01:00-03:00 – Dr. Cindy Bell's expertise in oral histopathology. 03:00-08:00 – Differentiating feline stomatitis and the need for biopsies. 08:00-11:00 – Discussing oral masses and the importance of a veterinary dentist. 11:00-13:00 – Practical advice on when to refer for oral masses.       (Veterinary dentistry, Oral inflammation in cats, Feline stomatitis vs gingivitis, Veterinary oral pathology, Board-certified veterinary dentist, Oral histopathology, Squamous cell carcinoma in cats)     Key Takeaways: Feline gingivostomatitis involves caudal oral mucosal inflammation, whereas other oral inflammations could simply be severe gingivitis. Only biopsy when necessary, especially if there is a unilateral mass indicating something more serious like squamous cell carcinoma. Always refer oral mass cases to a board-certified veterinary dentist for the best outcomes.     Affiliate & Sponsor Links: Veterinary Dental Practitioner Program: IVDI.org/INV  

Skin cancers run the gamut from relatively benign basal cell carcinoma to invasive melanoma. In between are squamous cell carcinomas, which are increasing in frequency and likely result in death more often than melanomas do, a new paper asserts, calling … Squamous cell skin cancer needs more rigorous study, Elizabeth Tracey reports Read More »

Please visit answersincme.com/UWE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in lung cancer discusses chemoimmunotherapy treatment of advanced squamous cell non-small cell lung cancer without molecular alterations. Upon completion of this activity, participants should be better able to: Describe the clinical profiles of approved chemoimmunotherapy combinations for treatment of patients with advanced squamous cell non-small cell lung cancer (NSCLC) without molecular alterations; Review clinical factors for individualizing first-line treatment of patients with advanced squamous cell NSCLC; and Identify real-world factors that impact treatment selection for patients with advanced squamous cell NSCLC. This activity is intended for US healthcare professionals only.

Everyone has heard a myth or two about cancer (hello, sugar!) The American Society of Clinical Oncology (ASCO) published eight "Myths and Facts About Cancer." Some of the myths they brought up were ones we've heard from patients, others...kind of cringey. We thought we should tackle them one by one. Not surprisingly, there is often a vein of truth that keeps these so-called myths alive. Tina and Leah have decades of experience as naturopathic physicians and have sifted through the data, so you don't have to! Just hit "play" and enjoy the show! We promise it's entertaining,  at the very least.ASCO's 8 Myths and Facts About CancerSpider Legs in Bubble Gum? Oh, that's a myth, alright.  Link to the truth re: spider legs in bubble gum.Link to our previous episode on sugar--  E58: Does Sugar Feed Cancer?Support the showWe hope you find our talks useful and entertaining! Please rate & review us! This helps us get found by listeners like you!Share this podcast with someone you love! https://www.thecancerpod.com Email us: thecancerpod@gmail.comWe are @TheCancerPod on: Instagram Twitter Facebook LinkedIn We appreciate your support! THANK YOU!

A new research paper was published in Oncotarget's Volume 14 on July 7, 2023, entitled, “Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.” Treatment for locally advanced cutaneous squamous cell cancers (laCSCC) remains poorly defined. Most laCSCC tumors express high levels of epidermal growth factor receptors (EGFR). Cetuximab has activity in other EGFR expressing cancers and enhances the effectiveness of radiotherapy. In this new study, researchers Mark Chang, Wolfram Samlowski and Raul Meoz from University Medical Center of Southern Nevada, Comprehensive Cancer Centers of Nevada, University of Nevada Las Vegas, and University of Nevada Reno conducted a retrospective review of institutional data and identified 18 patients with laCSCC treated with cetuximab induction and concurrent radiotherapy. “We performed a retrospectively review of treatment outcome and toxicity in our patients who received concurrent cetuximab and radiotherapy to show an additional potentially effective treatment option for patients with laCSCC. The goal is also to provide data to inform the design of potential prospective clinical trials.” The loading dose of cetuximab was 400 mg/m² IV. Subsequent weekly doses of 250 mg/m² IV were infused throughout the period of radiation. The treatment doses ranged from 4500–7000 cGy, with a dose fraction of 200-250 cGy. The objective response rate was 83.2% with 55.5% complete responses and 27.7% partial responses. Median progression-free survival was 21.6 months. Progression-free survival was 61% at 1 year and 40% at 2 years. With longer follow-up, some patients developed a local recurrence (16.7%), distant metastases (11.1%) or a second primary cancer (16.3%). Cetuximab was well tolerated, with 68.4% patients experienced only mild acneiform skin rash or fatigue (Grade 1 or 2). Radiotherapy produced expected side effects (skin erythema, moist desquamation, mucositis). “Cetuximab plus radiotherapy represents an active and tolerable treatment option for laCSCC, including patients with contraindications for checkpoint inhibitor therapy.” DOI - https://doi.org/10.18632/oncotarget.28470 Correspondence to - Wolfram Samlowski - wsamlowski1@gmail.com Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28470 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - keratinocyte carcinoma, squamous cell skin cancer, cetuximab, epidermal growth factor receptor, radiation therapy About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ For media inquiries, please contact: media@impactjournals.com.

Christine Ko, Professor of Dermatology and Pathology, Yale University, New Haven, Connecticut, USA, joins Jonathan to discuss her early career and the ever-increasing burden of skin cancer. Ko also introduces Jonathan to the field of transplant dermatology.   Use the following timestamps to navigate the topics discussed in this episode:  (00:00)-Introduction  (02:15)-Ko's journey into dermatology and dermatopathology  (04:31)-Squamous cell carcinogenesis  (08:45)-Why skin cancer is becoming more common  (11:11)-Transplant dermatology  (14.02)-Changes in education 

This podcast summaries the article 'Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease'.

Since recorded history, heartburn has been a common complaint and the descriptions from ancient physicians are virtually indistinguishable from today's accounts. However, one thing we do know that they did not is a small subset of patients whose long standing heartburn could predispose them to a precancerous condition known as Barrett oesophagitis. Barrett oesophagitis is caused by chronic gastro-oesophageal reflux disease with a number of known risk factors for developing this. These patients require regular monitoring +/- intervention as they have an increased rate of developing oesophageal adenocarcinoma. For this episode we have called in some specialists to help us out. Our guests include: Dr Tristan Rutland – Anatomical Pathologists who specialises in Gastrointestinal Pathology Dr Milan Bassan – Gastroenterologist who is Head of the endoscopic department at Liverpool Hospital This is the story of Barrett Oesophagitis.See omnystudio.com/listener for privacy information.

- Overview of Advanced Skin Cancers, including Advanced Basal Cell and Advanced Squamous Cell Cancers - New Treatment Approaches - Emerging Role of Targeted Therapy - Clinical Trial Updates - Managing Treatment Side Effects, Discomfort & Pain - Tips for Caring for Your Skin During Cancer Treatments - Sun & Wind Safety Tips - Communicating with Your Health Care Team about Quality-of-Life Concerns - The Increasing Role of Telehealth/Telemedicine Appointments - Questions for Our Panel of Experts

- Overview of Advanced Skin Cancers, including Advanced Basal Cell and Advanced Squamous Cell Cancers - New Treatment Approaches - Emerging Role of Targeted Therapy - Clinical Trial Updates - Managing Treatment Side Effects, Discomfort & Pain - Tips for Caring for Your Skin During Cancer Treatments - Sun & Wind Safety Tips - Communicating with Your Health Care Team about Quality-of-Life Concerns - The Increasing Role of Telehealth/Telemedicine Appointments - Questions for Our Panel of Experts

- Overview of Advanced Skin Cancers, including Advanced Basal Cell and Advanced Squamous Cell Cancers - New Treatment Approaches - Emerging Role of Targeted Therapy - Clinical Trial Updates - Managing Treatment Side Effects, Discomfort & Pain - Tips for Caring for Your Skin During Cancer Treatments - Sun & Wind Safety Tips - Communicating with Your Health Care Team about Quality-of-Life Concerns - The Increasing Role of Telehealth/Telemedicine Appointments - Questions for Our Panel of Experts

- Overview of Advanced Skin Cancers, including Advanced Basal Cell and Advanced Squamous Cell Cancers - New Treatment Approaches - Emerging Role of Targeted Therapy - Clinical Trial Updates - Managing Treatment Side Effects, Discomfort & Pain - Tips for Caring for Your Skin During Cancer Treatments - Sun & Wind Safety Tips - Communicating with Your Health Care Team about Quality-of-Life Concerns - The Increasing Role of Telehealth/Telemedicine Appointments - Questions for Our Panel of Experts

Episode 86. I discuss three types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Learn about these conditions that everyone should know, including the ABCs of melanoma (red flags to look out for when you do self-checks). Editing Service and One-on-One Consultation for Pre-Med and Medical Students (CV, personal statement, applications): ⁠https://www.fiverr.com/firstlinepod⁠  Visit First Line's website and blog: ⁠https://poddcaststudios.wixsite.com/firstlinepodcast⁠ For a discount off your TrueLearn subscription use link: ⁠https://truelearn.referralrock.com/l/firstline/⁠ and code: firstline Instagram: @firstlinepodcast Facebook: ⁠www.facebook.com/firstlinepodcast⁠ Email: firstlinepodcast@yahoo.com Content on First Line is for educational and informational purposes only, not as medical advice. Views expressed are my own and do not represent any organizations I am associated with.

In 2022, Dr. Mark Kris, the William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan Kettering Cancer Center, served as chair of Optimizing Management of Metastatic Squamous Non–Small Cell Lung Cancer (NSCLC), a continuing medical education (CME)/nursing continuing professional development (NCPD) activity. A year later, Dr. Kris sat down again with Oncology Data Advisor to share the progress that has occurred in this field and the important considerations to keep in mind when treating patients with squamous NSCLC in 2023.

Discover new developments in the management of metastatic squamous non–small cell lung cancer (NSCLC), including individualized care plans, efficacy and safety of novel therapies, and strategies to optimize survivorship for patients with NSCLC. This podcast is presented by expert faculty, Mark G. Kris, MD, Memorial Sloan Kettering Cancer Center, and Victoria Sherry, DNP, CRNP, AOCNP®, Nurse Practitioner, Abramson Cancer Center. Listen now to earn free CME/NCPD! To claim credit, click here: i3health.com/oda-squamous-nsclc

:45 What is the largest organ in your body?   3:30 New Technology   5:45 Wearing hats in Australia   6:00 Different types of skin cancers   7:20 Moh's Surgery   8:50 Squamous cell cancer   11:00 Wrinkling   12:30 How often should you get your skin checked?   Executive Medicine Moment: At Executive Medicine of Texas, we understand that true health can only be found when you treat the patient as a whole. That's why our Executive Physicals Exams are second to none in the amount of testing and information we gather prior to making a wellness plan for our patients. Lean more about how you can take charge of your health a EMTexas.com. Website: StayYoungAmerica.com Twitter: @StayYoungPod Facebook: @ Stay Young America!

Quadrare, quadratum; to square, to make four-cornered (quadriceps) Radius; rod, spoke, ray, beam; bone on outer forearm – radius (radius, dorsoradial, radioulnar, radiology) Ramus; branch (ramiform, ramus communicans – nerve which connects two other nerves) Rectus; right, straight (rectus abdominous, rectus femoris) Ren, renis; kidney (adrenalin, renal, circumrenal, prerenal) Rigor; stiffness, cold (rigor mortis) Scapula; shoulder, shoulder-blade (scapula, subscapula, infrascapular, scapuloclavicular, cervicobscapular) Scrotum; bag, pouch (scrotal, scrotum) Sebum; grease, fatty secretion (sebum) Sinister, sinistri; left, on the left (sinistrodextral, sinstrocular) Sinus; curve, cavity and/or recess (sinus, sinusoidal, Ethmoid sinus) Spina; thorn, spine (cerebrospinal, spina bifida, spinal erector) Spirare, spiratum; to breathe, blow (exspiration, inspiration, perspiration) Squama; scale, flake, thin plate (Squamous epithelial tissue, squamella) Stapes, stapedis; a stirrup, innermost ossicle of ear (extrastapedial, mediostapedial, stapes – involved in conduction of sound vibration) Stare, statum; to stand (distal) Sulcus; furrow, grove (costal sulci) Supinus; bending backwards, supine, lying on back (supination, supinator, supine, semisupination) Talus, ankle, ankle-bone (talus, talofibular, talotibial) Tempora; the temple (temporomandibular joint, temporal, infratemporal) Tender, tentum, tensum; to stretch (extensor, tendon, tensor fascia lata, hypertension) Tibia; pipe, flute; shinbone, the innder and larger bone of the lower leg (tibia, femorotibial) Tumere; to swell (tumor, tumentia) Ulcus, ulceris; open sore (ulcer, ulcerate) Ulna; elbow, inner and larger bone of the forearm (radioulnar, ulna) Umbilicus; the navel (umbilical cord, umbilicus) Unguis; nail, claw, hoof (subungual, unguis, ungula) Uva; grape (uvula – small lobe haning from palate) Vagus; wandering (vagus – nerve, valgus knee) Varus; crooked, bent inward (coxa vara, genu varum, pollex varus) Vas; vessel (vascular, cerebrovascular) Vellere, vulsum; to tear, puck (avulsion, evulsion) Vena; vein (intravenous, supervenosity, vein) Venter, ventris; to come (ventral- anatomical position, ventricle, ventrolateral) Verruca; a wart (verruca, verruciform) Vertebra; a joint (vertebrae) Vesica; bladder, blister (vesicle, vesicular, cervicovesicular) Villus; tuft of hair (villi, villiform, intervillous) Virus; potent juice, poison (virus) Vomer; plowshare, a bone in the septum (ethmovomerine, vomer, vomernasal) --- Support this podcast: https://anchor.fm/liam-connerly/support

In this podcast, Dr. Riddell Scott, a dermatologist with Ridgeview Medical Center and Clinics, leads the discussion about skin cancer. Dr. Scott discusses changes to our DNA, what dermatology office visits look like, types of skin cancer and treatments available, as well as prevention efforts.  Enjoy the podcast. Objectives:Upon completion of this podcast, participants should be able to: Explain the 3 main types of skin cancer and how they differ from each type. State how most skin cancers are treated. Identify how sun exposure contributes to the onset of skin cancer. Describe 3 activities that help to reduce skin cancer incidence. Counsel patients about skin cancer prevention efforts. CME credit is only offered to Ridgeview Providers & Allied Health Staff for this podcast activity. Complete and submit the online evaluation form, after viewing the activity.  Upon successful completion of the evaluation, you will be e-mailed a certificate of completion within approximately 2 weeks. You may contact the accredited provider with questions regarding this program at  rmccredentialing@ridgeviewmedical.org. To receive continuing education credit for this activity - click the link below, to complete the activity's evaluation. CME Evaluation (**If you are listening to the podcasts through iTunes on your laptop or desktop, it is not possible to link directly with the CME Evaluation for unclear reasons. We are trying to remedy this. You can, however, link to the survey through the Podcasts app on your Apple and other smart devices, as well as through Spotify, Stitcher and other podcast directory apps and on your computer browser at these websites. We apologize for the inconvenience.)  DISCLOSURE ANNOUNCEMENT  The information provided through this and all Ridgeview podcasts as well as any and all accompanying files, images, videos and documents is/are for CME/CE and other institutional learning and communication purposes only and is/are not meant to substitute for the independent medical judgment of a physician, healthcare provider or other healthcare personnel relative to diagnostic and treatment options of a specific patient's medical condition; and are property/rights of Ridgeview Medical Center & Clinics.  Any re-reproduction of any of the materials presented would be infringement of copyright laws.  It is Ridgeview's intent that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It is not assumed any potential conflicts will have an adverse impact on these presentations. It remains for the audience to determine whether the speaker's outside interest may reflect a possible bias, either the exposition or the conclusions presented. Ridgeview's CME planning committee members and presenter(s) have disclosed they have no significant financial relationship with a pharmaceutical company and have disclosed that no conflict of interest exists with the presentation/educational event. Thank-you for listening to the podcast. SHOW NOTES: *See the attachment for additional show information.  What happens to our DNA- Ultraviolet light hits skin and energy is transferred- Melanocytes & Melanin - Skin cancer risk factors Office visits- Family history - Dermatology: pattern recognition - Dermatoscope - Patient education - Repeat exams & recommendations - ABCDE (asymmatry, border irregularity, color variation, diameter, evolution)  Types of skin cancer: Squamous , Basal Cell Carcinoma, Melanoma- Cell physiology - Metastatic rate - Presentation - Primary vs secondary sources - Diagnosis - Stages (0,1,2) - Treatment (biopsy, MOHS, surgery, radiation, medication) Skin Cancer Prevention:- 3 Big Things:       - Wear a wide brimmed hat       - Wear sun protective clothing       - Wear sun screen daily - Sunscreen recommendations * For more information - see attached "Show Notes". Thanks for listening.

Episode 7 of the WatchRolling.com Podcast Veteran News: · VA establishes presumptive service connection for rare respiratory cancers for certain Veterans · Squamous cell carcinoma of the larynx · Squamous cell carcinoma of the trachea · Adenocarcinoma of the trachea · Salivary gland-type tumors of the trachea · Adenosquamous carcinoma of the lung · Large cell carcinoma of the lung · Salivary gland-type tumors of the lung · Sarcomatoid carcinoma of the lung · Typical and atypical carcinoid of the lung VA Press Release: https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5786 VA Exposures & Burn Pits Information: https://www.publichealth.va.gov/exposures/burnpits/index.asp VA Supplemental Claim Link: https://www.va.gov/decision-reviews/supplemental-claim/ Watch Related News: 5 YouTube Channels I Enjoy: So Cal Watch Reviews So Cal Watch Reviews: https://www.youtube.com/c/SoCalWatchReviews Relojeando (Miguel's Spanish Language Channel): https://www.youtube.com/channel/UCA72WWAAHIPKjNAcjvPfJXA Ross Wrist Watch Love: https://www.youtube.com/c/RossWristWatchLove Rico' Watches Podcast Rico's Watches Podcast: https://www.youtube.com/channel/UCKu6R3B8QnP91hM3P51_Qbw The Watch Idiot The Watch Idiot: https://www.youtube.com/c/TheWatchIdiot Somewhere in Time & Watch the Time Somewhere in Time: https://www.youtube.com/c/somewhereintimewatchreviews Watch the Time: https://www.youtube.com/c/WatchtheTime Federico Talks Watches Federico Talks Watches: https://www.youtube.com/c/FedericoTalksWatches Del Ray Watch: https://delraywatch.com/ (not an affiliate link) Admin: This episode is sponsored by Mushi Watch Straps, a Veteran-Owned Company that makes stylish, durable, and fairly priced watch straps and accessories. Give them a visit for all your watch strap and accessory needs: www.mushiwatchstraps.com Visit https://www.watchrolling.com/ for Veteran Resources, articles, and more cool watch-related stuff. For WatchRolling.com merch: https://www.watchrolling.com/merch (a percentage of all proceeds will go the Veteran's Watchmaker Initiative) and remember, at WatchRolling.com-"You make the watch; the watch doesn't make you." --- Support this podcast: https://podcasters.spotify.com/pod/show/watchrollingpod/support

Discover new developments in the management of metastatic squamous non–small cell lung cancer (NSCLC), including individualized care plans, efficacy and safety of novel therapies, and strategies to optimize survivorship for patients with NSCLC. This podcast is presented by expert faculty, Mark G. Kris, MD, Memorial Sloan Kettering Cancer Center, and Victoria Sherry, DNP, CRNP, AOCNP®, Nurse Practitioner, Abramson Cancer Center. Listen now to earn free CME/NCPD!

What is that growing on me -- could it be skin cancer? Have you asked yourself this question? During the pandemic I ignored a couple of what I thought were pimples because I was terrified to go inside a building. According to Wikipedia... Squamous cell carcinoma of the skin is usually not life-threatening, though it can be aggressive. Although the nonmelanoma skin cancer basal cell carcinoma (BCC) is rarely life-threatening, it can be troublesome, especially because 80 percent of BCCs develop on highly visible areas of the head and neck. Mayo Clinic Apparently I have, or had, both. After a few biopsies, a topic chemotherapy treatment, and now Mohs surgery, I hope this closes a chapter. Yet it seems nearly inevitable that there will be a recurrence. And thus my education on this topic is in its genesis. A few takeaways from this experience -- don't leave the house without sunscreen protection and learn more to successfully advocate for myself. Here's an entry from a chronic illness blogger about her ordeal with skin cancer.

In this week's cover paper of Oncotarget (Volume 12, Issue 11) entitled, "CEA as a blood-based biomarker in anal cancer," researchers from The University of Texas – MD Anderson Cancer Center, Terasaki Foundation of Biomedical Sciences, and Vanderbilt Ingram Cancer Center conducted a retrospective, single-institution study to determine the correlation between carcinoembryonic antigen (CEA) levels (a commonly employed assay for patients with colorectal adenocarcinoma) and biopsy-proven Squamous cell carcinoma of the anal canal (SCCA). The researchers retrospectively analyzed 219 patients who were treated at The University of Texas – MD Anderson Cancer Center between 2013 and 2020. The team collected demographic data, clinical history, and CEA levels, including gender, ethnicity, stage at initial diagnosis of SCCA, HPV status, HIV status, and smoking history. Patients with coexisting second primary cancers besides SCCA were excluded from their analysis. The median age of patients in the study was 56 years old, 74% were female, and 89% were of Caucasian ethnicity. At the time of the initial CEA measurement, patients were at various stages of SCCA, with 39% in stage III and 41% with metastatic disease to distant organs. 67% of patients had currently or previously tested positive for HPV infection. Statistical analysis was calculated using the summarized demographic and clinical characteristics of patients as means with associated standard deviations. “Here we report the largest series detailing the relevance of CEA as a biomarker for patients with SCCA.” Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.27959 DOI - https://doi.org/10.18632/oncotarget.27959 Full text - https://www.oncotarget.com/article/27959/text/ Correspondence to - Van K. Morris - vkmorris@mdanderson.org Keywords - carcinoembryonic antigen, squamous cell carcinoma of anal canal, anal cancer, biomarkers, HPV About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget YouTube - https://www.youtube.com/c/OncotargetYouTube/ LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Skin cancer is a highly preventable cancer (in non-hereditary cases), due to a major risk factor being prolonged exposure to ultraviolet (UV) radiation. However, skin cancer is the most commonly diagnosed cancer in the United States. By the age of 70, one in five Americans are predicted to be diagnosed with skin cancer. There are three types of cells that are usually involved in skin cancer: basal cells, squamous cells, and melanocytes (or pigment producing cells). The type of skin cell affected by cancer is what classifies the difference between basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma is the most common and most treatable form of skin cancer. Basal cell carcinomas grow slowly and cause minimal damage if detected and treated early. The second most common form of skin cancer is squamous cell carcinoma. Squamous cell carcinoma of the skin may also be termed cutaneous squamous cell carcinoma, in order to differentiate from other squamous cell cancers that may occur in the body. Melanoma of the skin is the mutation, often followed by the rampant division, of the skin’s melanocytes. It is the most serious type of skin cancer due to its tendency to spread to other organs. Surprisingly, as much as 30% of all melanoma cases are a result of factors other* than exposure to the sun or other UV light. The causes of such cases are still unknown to researchers, but some suggest that causes could be hereditary. Oncotarget’s Special Collection on Skin Cancer & Melanoma is intended to be a tool for researchers and science readers alike to learn more about the current landscape of skin cancer. The creators of these collections are hopeful that this resource may help researchers discover new biomarkers, mechanisms, and therapies that improve our collective quality of life and lead to enhanced treatments for cancer and other diseases. Papers within this Special Collection relate to various topics on skin cancer research, including a 2018 paper from Australia on the first blood test for early detection of melanoma, a paper by researchers from Columbia University on a combined therapeutic approach that improves anti-tumor antibody therapy in melanoma, and many more. Read Oncotarget’s Special Collection on Skin Cancer: https://www.oncotarget.com/collections/skin-cancer/ Visit the Special Collections Archive: https://www.oncotarget.com/collections/ About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget YouTube - https://www.youtube.com/c/OncotargetYouTube/ LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Its skin cancer and melanoma awareness month. The health of our skin is so important! It is after all our largest organ. Kingslea is a board certified nurse practitioner and Certified Aesthetic nurse specialist. She has spent years specializing in dermatology, dermatologic surgery , skin lesions, acne, rosacea, skincare and now aesthetics.  Topics of discussion- Difference between Melanoma vs Basal cell and Squamous cell carcinoma- How to recognize changes in your skin - Common places for skin lesions to pop up- Difference between physical vs chemical sunscreen- Whats a good vitamin C and why is it important- Difference between physical vs chemical exfoliants- A simplistic skincare routine we all should be following - The antiaging trio - Some of Kingsleas favorite products Connect with Kingslea on instagram @dr.kingsleaShop some of here favorites at http://ellaora.comAlso favorite body sunscreens (Hint mineral based)Blue lizardCerave hydrating mineral sunscreen 

A demo ad read, likely read by Loy P. Thompson, a company rep for Squamous Foetor. Recorded in 1950.

This episode covers the basics of squamous cell carcinomas, incl biology, cancer staging and management

Review Epidermis = top layer of skin.  Living cells divide and then add in proteins that causes cells to harden as they die and become and protective layer to keep out water and dirt and critters.  Some of those proteins give your skin its color (melanin) and they help block and reflect UV light from the sun to keep the living cells from being damaged. Mutations = if UV light damages the cells' DNA, then when the cells divide and replicate, they copy the "error" and reproduce an abnormal cell.  If certain mutations cause the cells to die, others cause the cells to be weak, but others cause the cells to become cancer. 3 types of skin cancer Basal cell carcinoma - most common of these 3, more common in people with fair skin.  Skin growth is flesh colored, can look like skin tags.  Caused when a basal cell gets mutated and starts to grow. Squamous cell carcinoma - more common in people with fair skin. Scaly patches or sores that open, start to heal but reopen and never heal.  Caused when a keratinocyte (living, dividing skin cell) gets mutated in the middle of replicating. Melanoma - Moles are just a place where a lot of melanocytes gather in one place, but sudden moles or dark spots can be the tip of a bad iceberg.  This is the deadliest type of skin cancer.  Caused by mutations in the melanocytes. Some benign (harmless) skin characteristics can resemble skin cancer, thus it's easy to overlook them in the early stages. A tool for early detection of melanoma A - Asymmetry - you can't fold it in half and all the edges match B - Boarder - jaggedy, sharp boarders C - Color - uneven color D - Diameter - > 6mm (bigger than the eraser of a #2 pencil) E - Evolving - changes shape, size, or color in a short amount of time (< 1 month) This is why the National Skin Cancer Foundation recommends you do a monthly skin scan to check skin characteristics for changes or new ones. Early detection is the number one step to improve survival of all cancers. Precancer = Actinic Keratosis - dry and flakey places in the skin, can be the precursor of Squamous Cell Carcinoma.  Usually shows up after 40 years old. Cancer is not just a disease that happens to the aged, but as you age, the probability of you being exposed to something that could mutate your cells goes up. Connect with me Support us on Patreon *NEW* Join the Pharmacist Answers Podcast Community on Facebook Subscribe: iTunes, Stitcher, GooglePlay, TuneIn Radio Like the Facebook page Music Credits:  “Radio Martini” Kevin MacLeod (incompetech.com)  Licensed under Creative Commons: By Attribution 3.0  http://creativecommons.org/licenses/by/3.0/

Should nine-year-old Chihuahua with squamous cell on his tongue have definitive radiation

The search for my cat leads me halfway up the High Street, where the writhing tentacles of the Leviathan tower over us all. transcript: https://thelostcatpodcast.tumblr.com/post/184135236497/the-lost-cat-podcast-transcripts-s01-ep03-the